|Slideshows|October 28, 2019

Statements from organizations regarding breastfeeding and substance use

Author(s)Marguerite Lisa Bartholomew, MD, Men-Jean Lee, MD

These four statements can help provide ob/gyns with guidance about how to counsel patients with substance use disorder about breastfeeding.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!

Related Content

Continuous glucose monitoring reduces risk of large-for-gestational-age births in gestational diabetes

ByMorgan Ebert, Managing Editor

December 5th 2025

Maternal vitamin D levels during pregnancy linked to dental caries risk in offspring

ByMorgan Ebert, Managing Editor

December 3rd 2025

NAD-related metabolites are potential biomarkers for recurrent pregnancy loss

ByCeleste Krewson, Assistant Editor

December 3rd 2025

GLP-1 discontinuation tied to increased weight gain and pregnancy complications

ByMorgan Ebert, Managing Editor

December 2nd 2025

Optical genome mapping shows promise in predicting pregnancy loss

ByCeleste Krewson, Assistant Editor

December 1st 2025

Latest CME

Multimedia

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Multimedia

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Statements from organizations regarding breastfeeding and substance use

Newsletter

Related Content

Continuous glucose monitoring reduces risk of large-for-gestational-age births in gestational diabetes

Maternal vitamin D levels during pregnancy linked to dental caries risk in offspring

NAD-related metabolites are potential biomarkers for recurrent pregnancy loss

GLP-1 discontinuation tied to increased weight gain and pregnancy complications

Optical genome mapping shows promise in predicting pregnancy loss

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

DARE to PLAY sildenafil cream becomes commercially available for women in select states

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea

High costs and transfusions linked to acute heavy menstrual bleeding

FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea

Contemporary OB/GYN week in review: HPV vaccine, postpartum depression, and more